Performance of Bleeding Risk Scores in Predicting Bleeding Complications in Korean Patients Who Are Receiving Dual Antiplatelet Therapy for Acute Coronary Syndrome

Am J Cardiol. 2022 Feb 15:165:131-132. doi: 10.1016/j.amjcard.2021.10.014. Epub 2021 Dec 7.

Authors

Pil Sang Song¹, Kye Taek Ahn¹, Jae-Hyeong Park¹, Do-Yoon Kang², Duk-Woo Park², Si Wan Choi¹; TICAKOREAE Investigators

Affiliations

¹ Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, South Korea.
² Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

PMID: 34887072
DOI: 10.1016/j.amjcard.2021.10.014

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Coronary Syndrome / drug therapy*
Dual Anti-Platelet Therapy / adverse effects*
Hemorrhage / chemically induced
Hemorrhage / epidemiology*
Humans
Logistic Models
Proportional Hazards Models
Republic of Korea / epidemiology
Risk Assessment / methods